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Abstract
Hyperglycemia may cause profound deficits of water, sodium and potassium through osmotic
diuresis, which continues during treatment as long as there is glucosuria. Replacement fluids
should cover both the deficits at presentation and the ongoing losses during treatment. At
presentation with hyperglycemia, quantitative estimates of the deficits in water, sodium and
potassium are based on rapid body weight changes, which indicate changes in body water, and
on the serum sodium concentration corrected to a normal serum glucose level. The corrected
serum sodium concentration provides a measure of the water deficit relative to the cation deficit
(sodium, plus potassium) that is useful in guiding the choice of monovalent cation concentration
in the initial replacement fluids. Monitoring clinical status, serum chemistries (glucose, sodium,
potassium, total carbon dioxide), urine flow rate, and urine chemistries (sodium and potassium)
during the course of fluid and cation replacement therapy is critical. This monitoring guides the
volume and composition of replacement solutions for deficits developing during treatment and
the management of potassium balance and acid-base abnormalities, including metabolic
acidosis, respiratory acidosis, rarely, and others.
Categories: Endocrinology/Diabetes/Metabolism, Internal Medicine
Keywords: osmotic diuresis, hyperglycemia, hypovolemia, hypertonicity, hypokalemia
Introduction And Background
Deficits in body water and electrolytes complicating severe hyperglycemic syndromes may
aggravate their outcomes [1]. For this reason, evidence-based guidelines place emphasis on the
quantity and composition of the replacement solutions [1-4]. Adherence to guidelines improves
the outcomes of severe hyperglycemic syndromes [5-6]. Although the guidelines recognize the
importance of fluid replacement, they recommend fixed initial rates of infusion of 0.154 m saline
and do not provide details for the subsequent management of patients with extreme fluid deficits
[1-2, 4]. Because fluid replacement in these extreme cases requires large volumes, errors can also
be large. Individualizing replacement by careful computations of deficits may complement the
guidelines and may prevent errors.
This report reviews the pathogenesis of fluid and solute abnormalities in hyperglycemic
syndromes and describes a quantitative method for their correction. Fluid and solute losses
occur both prior to presentation with hyperglycemia and during its treatment. Accurate
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estimates of existing water and monovalent cation losses at presentation with hyperglycemia
and of changes in body water and monovalent cations occurring during treatment are critical.
These estimates guide individualized quantitative estimates of fluid replacement. Data from two
patients with extreme hyperglycemia are used to illustrate the applications of the method
presented. We suggest that simplicity without loss of accuracy is an advantage of this method.
Rigorous, but more complex, methods calculating the replacement solutions have been reported
[7-8]. Table 1 shows the abbreviations used in this report.
Abbreviation Explanation
Serum glucose concentration 
Serum sodium concentration 
Change in serum sodium concentration as a consequence of the change in serum glucose
concentration 
Dialysis-associated hyperglycemia 
Diabetic ketoacidosis in patients with preserved renal function 
Non-ketotic hyperosmolar hyperglycemia in patients with preserved renal function 
Serum osmolality 
Urine osmolality 
Urine volume 
The part of urine volume that is solute-free (pure water) 
The part of urine volume that is electrolyte-free 
Sodium concentration in urine 
Potassium concentration in urine 
Serum chloride concentration 
Serum total carbon dioxide 
Intensive care unit 
Serum potassium concentration 
Body weight (body water) difference between the normal state and the state of presentation with
hyperglycemia. 
TABLE 1: Abbreviations used in this report
Review
Body water (body weight) changes in hyperglycemic syndromes
Rapid (e.g. hours to days) changes in body weight reflect body fluid changes of equal magnitude.
The difference between the most recent previous recording of body weight and its measurement
at presentation with hyperglycemia provides a quantitative estimate of the net loss in body water
from hyperglycemia. Consequently, recent weight loss, when known, provides an estimate of the
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volume of water required to replete the water already lost at presentation. When the weight lost
is not known, a reasonable approximation may be that patients presenting with severe
hyperglycemia have lost about 9 L of fluids [2, 4] or ≥ 25% of their total body water.
Symptomatic volume deficits at presentation should be replaced promptly by infusion of large
volumes of saline, often containing potassium salts, until the symptoms of hypovolemia have
abated. Large fluid losses occur also during treatment, as long as serum glucose concentration 
 remains high, and should be replaced. For this reason, weight changes during
treatment should be recorded frequently [4]. Vital signs, such as the pulse rate and blood
pressure, are also critical in monitoring the adequacy of fluid replacement and in guiding
treatment changes.
Changes in serum tonicity in hyperglycemic syndromes from
gains in extracellular solute
Serum tonicity, or effective osmolarity, is the part of total serum osmolarity attributable to
extracellular solutes that don’t rapidly enter cells and therefore cause steady state osmotic fluid
shifts from the intracellular into the extracellular compartment when their extracellular
concentration is high [9]. The clinical manifestations of hypertonicity result primarily from
reductions in the volume of brain cells [10] and are neurological (headache, coma, seizures, and
death).
Disturbances in serum tonicity are the consequence of imbalances in the relation between body
water, total body solute and body monovalent cations. Sodium salts are the main extracellular
solute. The concentration of sodium in serum  is an accurate index of tonicity if there
is no excess of extracellular solute other than sodium salts or decrease in plasma water content
[11-15]. Hypernatremia indicates an abnormally high ratio body (extracellular) sodium-to-body
water regardless of whether total body sodium is below normal, normal or excessive [11] and
indicates, without exception, the presence of hypertonicity. Hyperglycemia is a hypertonic state
which may be associated with low, “normal”, or high .
Hyperglycemia causes hypertonicity by two distinct mechanisms, extracellular solute (glucose)
accumulation and osmotic diuresis. Although these two mechanisms have additive effects on
tonicity, they have opposing effects on . A gain in extracellular glucose content, without
any change in body water or monovalent cations, causes hypertonicity [9]. An increase in serum
glucose concentration  leads to osmotic transfer of intracellular water into the
extracellular compartment resulting in dilution of extracellular solutes and hyponatremia [16].
An approximation of serum tonicity at hyperglycemia is provided by formula 1 in Table 2 [17].
Formulas used in this report
Tonicity formula: 
when  is in mmol/l 
when ( ) is in mg/dl
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The Katz formula (20): 
or 
 = change in .  = change in  resulting from 
Corrected  (21): 
when  is expressed in mmol/l, or 
when  is expressed in mg/dl
Solute-free water loss in the urine : 
 = the urine volume in the period studied
Electrolyte-free water loss in the urine : 
,  = urinary sodium and potassium concentration respectively.
The Mellits-Cheek formula for boys (43): 
, the body water in the normal state, is in liters,  is in kilograms and  is in centimeters
TABLE 2: Formulas used in this report
Conversely, the literature [18-19] provides both indirect and direct evidence strongly suggesting
that serum tonicity decreases during correction of hyperglycemia without any further changes in
body water or monovalent cations.
Indirectly, a balance study reported net loss of body solute not accounted for by changes in the
external balances of solute or water during correction of hyperglycemia [18]. Directly, serum
tonicity decreased in anuric patients during correction of hyperglycemia by the use of only
insulin infusion [19]. Therefore, the formula estimating serum tonicity at hyperglycemia (formula
1 in Table 2) is not appropriate as a guide to the tonicity of the initial replacement solution. What
is needed is an accurate prediction of the final euglycemic  if hyperglycemia were to be
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corrected without any further changes in water or cation balances.
Katz [20] proposed that a decrease in  by 5.6 mmol/L (100 mg/dL) results in an increase
in  by 1.6 mEq/l (  = -1.6 mEq/l per 5.6 mmol/L or -0.2857 mEq/l per mmol/L,
formula 2 in Table 2). Al-Kudsi, et al. [21] used Katz’s formula to predict the corrected ,
that is the value of  if hyperglycemia is corrected to a  of 5.6 mmol/L without any
further changes in body water or cations (formula 3 in Table 2). The corrected  predicts
serum tonicity after normalization of  and should guide the selection of the tonicity of
replacement fluids.
Unlike severe volume deficits which should be corrected promptly, correction of severe
abnormalities in tonicity should be slow. The hourly rate of decline in serum tonicity proposed in
the evidence-based guidelines is ≤ 3 mOsm/l [2]. The rationale for this proposal is prevention of
cerebral edema, which is a devastating complication of severe hyperglycemia associated usually
with ketoacidosis. It has also been reported that both the magnitude and the rate of development
of hyperglycemic hypertonicity are important causes of severe neurologic manifestations in
hyperglycemia [22].
A decrease in  by 5.6 mmol/L without any other change would cause a 5.6 mOsm/l
decrease in serum tonicity, while an increase in , by 1.6 mEq/l would cause an increase in
serum tonicity by 3.2 (= 2 x 1.6) mOsm/l. Therefore, the net effect of correction of hyperglycemia,
according to Katz’s formula (20), would be a decrease by 2.4 (= 5.6 – 3.2) mOsm/l for each decline
in  by 5.6 mmol/l [19]. The hourly rate of decline in  proposed in the guidelines
[2], at 2.8-4.2 mmol/l (50-75 mg/dl), would thus produce a rate of decline in serum tonicity
between 1.2 and 1.8 mmol/l per hour. Corrected  should also decrease, if its presenting
value is elevated. With the recommended rate of decline in tonicity through correction of
hyperglycemia, the desired rate of decline in corrected  is 0.6-0.9 mEq/l hourly.
Figure 1 shows the relation between , measured , serum tonicity and corrected 
 defined by the Katz [20] and Al-Kudsi [21] formulas. The important feature of this Figure
is that the corrected  is equal to the measured  at euglycemia and is the only
parameter that remains constant throughout the range of hyperglycemia. Therefore, the
corrected  represents the most appropriate parameter for evaluating tonicity during
treatment of hyperglycemic syndromes. The provision for this use of corrected  is that
clinical observations should confirm Katz’s theoretical calculation, which is based on a closed
system without any changes in the external balance of monovalent cations or water.
Observations in patients with end-stage renal disease, who, by and large, represent closed
systems, confirmed Katz’s number [19, 23-26]. An example of the effect of correction of anuric
hyperglycemia on serum tonicity is shown below.
1" itemprop="image"
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FIGURE 1:
Changes in serum tonicity, measured serum sodium concentration and corrected serum sodium
concentration in progressive hyperglycemia predicted by Katz [20] and Al-Kudsi et al. [21].
Regardless of the level of hyperglycemia, which affects both serum tonicity and measured serum
sodium concentration, the corrected serum sodium concentration remains constant and equal to
the baseline measured serum sodium concentration.
Table 3 shows sequential changes in serum chemistries in an anuric man (Patient 1), who had
exhibited intense thirst and consumption of large volumes of water in the two days prior to
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admission with hyperglycemia and was treated with insulin infusion. Body weight measurements
were exactly the same at presentation and after correction of hyperglycemia 16 hours later. The
main findings of Table 3 are as follows: (a) Each decrease in  was accompanied by an
increase in  and a decrease in serum tonicity, while the corrected  remained the
same in each step and was equal to the measured final euglycemic . These findings are
consistent with Figure 1. (b) The average hourly rate of decline in  was 3.9 mmol/L (70.2
mg/dL) and the average hourly rate of decrease in tonicity was 1.78 mmol/L. Both rates of decline
were within the rates recommended by the guidelines [2]. (c) Overall  was -1.55 mEq/l
per 5.6 mmol/L and tonicity decreased by 2.46 mOsm/l per 5.6 mmol/L decrease in .
These estimates confirm Katz’s predictions [20]. (d) At euglycemia, the patient exhibited
substantial hypotonic hyponatremia, an apparent consequence of water intake during
development of hyperglycemia.
Glucose mmol/L
(mg/dL)
Sodium
Measured mEq/l
Potassium  
mEq/l
Chloride  
mEq/l
Total CO2
mmol/L
Anion Gap
mEq/L
Tonicity  
mOsm/l
Sodium
Corrected mEq/l
68.9 (1240) 103 5.7 69 22 12 274.9 121.2
47.6 (856) 109 4.6 75 22 12 265.5 121.1
34.0 (612) 113 4.1 80 22 11 260.0 121.2
23.5 (423) 116 3.9 82 22 12 255.5 121.2
4.4 (80) 121 3.9 87 21 13 246.4 120.7  
TABLE 3: Sequential serum chemistry values in an anuric hyperglycemic patient treated with insulin infusion. Patient 1.
On admission with extreme hyperglycemia, serum urea was 50.4 mmol/l and measured serum osmolality 338 mOsm/kg. At
euglycemia, serum urea was 51.1 mmol/l and measured serum osmolality 311 mOsm/kg.
On admission with extreme hyperglycemia, serum urea was 50.4 mmol/l and measured serum
osmolality 338 mOsm/kg. At euglycemia, serum urea was 51.1 mmol/l and measured serum
osmolality 311 mOsm/kg.
Effects on serum tonicity of losses of water and monovalent
cations from glucosuria
The management of hypertonicity can become a central concern during treatment of
hyperglycemia in patients with preserved renal function who, unlike patients with absent renal
function, develop external losses of water, sodium and potassium causing rises in tonicity that
are added to those caused by hyperglycemia. Unlike hypertonicity caused by hyperglycemia,
which requires only insulin for its reversal (25, 27), hypertonicity resulting from external losses
of fluids must be corrected by careful choice of the volume and composition of the replacement
solutions.
Figure 2 shows simulated , measured and corrected, resulting from simultaneous
development of both hyperglycemia and osmotic diuresis with varying degrees of electrolyte-
free water loss in the urine. Progressive urinary loss of electrolyte-free water causes rises in both
measured , which may exceed the normal range of  despite an osmotic shift of
intracellular water into the extracellular compartment, and corrected , which provides a
true reflection of the relative water deficit.
2" itemprop="image"
2013 Tzamaloukas et al. Cureus 5(3): e110. DOI 10.7759/cureus.110 6 of 17
src="http://assets.cureus.com/uploads/figure/file/768/article_river_2048fig2.png" title="Figure 2" />
FIGURE 2:
Relationship between measured and corrected serum sodium, serum glucose and electrolyte-
free water elimination in the urine. The measured and corrected serum sodium values were
calculated according to Katz (20) and Al-Kudsi et al. (21). The electrolyte-free water elimination in
these simulations is a calculated value considering only electrolyte-fee water loss and assuming
initial measured serum sodium concentration of 140 mEq/l, serum (and total body) potassium
held constant and an initial body water of 40 liters. Please note that the values of measured and
corrected serum sodium concentration are the same when electrolyte-free water elimination is
zero.
Figure 3 illustrates hypertonicity caused by hyperglycemia alone and by a combination of
hyperglycemia, plus external losses in actual hyperglycemic syndromes. This Figure shows the
average values of , , and corrected  from large numbers of episodes of
dialysis-associated hyperglycemia (D-AH), and diabetic ketoacidosis (DKA) and nonketotic
hyperosmolar hyperglycemia (NKH) in patients with preserved renal function [25]. In D-AH, the
average corrected  was slightly below the normal range of , because hyperglycemia
causes thirst and fluid consumption, which is translated in weight gain [28-30], modestly
depressed values of corrected  and, in approximately one-third of the episodes, usually
modest hypotonicity after correction of the hyperglycemia with insulin [24]. Severe
hypertonicity, reported in the past in DAH episodes after dialysis with 7% dextrose dialysate,
which is not available nowadays, has not been reported recently.
3" itemprop="image"
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FIGURE 3:
Average serum glucose ([Glu]S, in mmol/l, plus measured ([Na]S and corrected serum sodium
(C[Na]S) concentrations, in mEq/L, from a review analyzing 491 episodes of dialysis-associated
hyperglycemia (D-AH), 1036 episodes of diabetic ketoacidosis (DKA) with preserved renal
function and 403 episodes of non-ketotic hyperglycemia with hypertonicity (NKH) in patients with
preserved renal function [25].
Average reported corrected  was modestly above the normal range in DKA and
substantially above normal in NKH, in which average measured  was also above the
normal range, despite the extreme hyperglycemia (Figure 3). These findings in actual patients
verify Figure 2. 
Figure 4 shows percentages of the rise in tonicity above normal attributed to hyperglycemia and
to changes in the external balances of water, sodium and potassium in the cases analyzed in
Figure 3. Katz’s estimate of a rise in serum tonicity by 2.4 mOsm/l for each 5.6 mmol/l rise in 
 was used to calculate the part of the rise in tonicity attributable to hyperglycemia in
Figure 4. The question as to whether Katz’s estimate is applicable to hyperglycemia developing
in patients with preserved renal function has been addressed by theoretical analyses [31],
retrospective observations [32-34] and prospective studies [35]. These studies found a wide
variation of the value  , at random variance with Katz’s prediction despite the analysis
performed or the study type.
All studies of the effect of hyperglycemia on  in patients with preserved renal function
[31-35] addressed development of hyperglycemia. Osmotic water translocation from the
intracellular into the extracellular compartment, the only abnormality involved in Katz’s
calculations, is not the only, or even the largest influence, on  during development of
2013 Tzamaloukas et al. Cureus 5(3): e110. DOI 10.7759/cureus.110 7 of 17
hyperglycemia in many cases (Figure 4). The question that needs to be addressed is whether the
corrected  based on Katz’s formula provides an accurate prediction of the final
euglycemic . This question cannot be easily addressed by clinical studies because of the
need for infusion of large volumes of saline during treatment of severe hyperglycemia [1-4].
Theoretical calculations suggest that the error of Katz’s formula is much smaller during
correction of hyperglycemia, if no further changes in water and cation balance take place, than
during the development of hyperglycemia, allowing the use of the corrected  as a guide of
the tonicity of the initial replacement solutions (Tzamaloukas, et al., unpublished observation).
Recent analyses of changes in  during various states causing fluid abnormalities,
including hyperglycemia [36], have adopted Katz’s formula.
4" itemprop="image"
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FIGURE 4:
Percent of hypertonicity (serum tonicity above 285.6 mOsm/l) attributable to hyperglycemia
(blue), using Katz’s calculation that a 5.6 mmol/l rise in serum glucose concentration causes a 2.4
mOsm/l rise in serum tonicity (19, 20), and to the net external losses of water and monovalent
cations (red) in the patients shown in Figure 3. Note that in patients with NKH and preserved renal
function the percent of hypertonicity attributable to hyperglycemia was substantially lower than in
the other two hyperglycemic syndromes even though NKH patients had a higher serum glucose
concentration. This reflects the extreme hypertonicity of the NKH group.
In D-AH, the average rise in serum tonicity was less than the value calculated by Katz’ formula
because of retention of the ingested water (Figure 4). In DKA, approximately two-thirds of the
rise in tonicity was caused by hyperglycemia and one-third by changes in the external balances,
while in NKH more than two-thirds of the rise in serum tonicity were attributed to external losses
despite a higher mean  value in this hyperglycemic subset than in D-AH or DKA (Figure
3). As shown in Figures 2 and 3, hypernatremia rather than hyponatremia, has been observed in
extreme cases of hyperglycemia in patients with substantial renal function [25, 37].
Hypernatremia is an index of extreme hypertonicity in hyperglycemia.
Understanding the pathogenesis of hypertonicity resulting from glucosuria requires an analysis
of body water and monovalent cation balances in this clinical setting. Osmotic diuresis is a
consequence of the presence in the serum of large quantities of solutes that cross freely the
glomerular filter, but exhibit various degrees of resistance to tubular reabsorption [38]. Solutes
responsible for osmotic diuresis may be distributed either in total body water (e.g. urea) or in the
extracellular compartment (e.g. glucose in hyperglycemic states). Osmotic diuresis caused by
glucosuria [39] may lead to large body deficits in water, deficits in electrolytes, mainly sodium
and potassium, and hypertonicity.
For any type of diuresis, including osmotic diuresis, the effect of the urinary losses of solute and
water on serum tonicity was traditionally analyzed by assuming that urine volume consists of
two parts, isotonic losses and either a) pure water loss if urine osmolality  is less
than serum osmolality , or b) net reabsorption of filtered water above the
reabsorption of solute if  is higher than . The formula for solute-free water
loss in the urine ( , formula 4 of Table 1) utilizes  and  as
determinants of .
In osmotic diuresis  is higher than  [39-40]. This finding, universal in the
absence of diabetes insipidus [41], led to the conclusion that a mechanism for relative water
conservation is operative in osmotic diuresis [40]. However, the effect of osmotic diuresis on
serum tonicity is exerted not through the relative losses of water and total solute, but through
the relative losses of water and electrolytes (sodium, plus potassium) in the urine. This is a
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consequence of the observation that the only determinant of  in the euglycemic state is
the ratio of the sum of total body sodium, plus total body potassium over total body water [42].
The electrolyte-free urine flow rate  substitutes the sum of urinary sodium and
potassium concentrations  for  and  for  in the
solute-free urine volume formula (43). Formula  (formula 5 in Table 1), but not
formula , determines the effect of urinary water and electrolyte losses on the
euglycemic  (that is on serum tonicity). The sum  is less than 
in osmotic diuresis [39]. Therefore, water loss is relatively greater than electrolyte loss [39] and
osmotic diuresis inadequately compensated for water loss leads to hypernatremia and
hypertonicity [44-46].
In summary, hyperglycemia exerts two opposite influences on . The osmotic transfer of
intracellular fluid into the extracellular compartment causes decreases in . Correction of
this change in  requires only correction of hyperglycemia and no fluid infusions, because
correction of the hyperglycemia will correct the internal fluid maldistribution. The hyperglycemic
osmotic diuresis causes a disproportionately larger loss of water than of sodium and potassium
resulting in rises in . Replacement of losses secondary to osmotic diuresis that were
acquired prior to presentation requires an estimate of the  value that would result if
osmotic diuresis were the only influence on  (the corrected ).
Calculations of water and cation deficits in severe
hyperglycemia
Diabetic ketoacidosis is considered severe when  > 13.9 mmol/l (250 mg/dl), arterial pH <
7.00, serum bicarbonate < 10 mmol/L, serum tonicity variable, serum anion gap 
 > 12 mEq/l, where  and  are
respectively the serum chloride and total CO2 concentrations, and presence of stupor or coma.
Hyperglycemic hyperosmolar syndrome is considered as severe if  > 33.3 mmol/l (600
mg/dl), arterial pH > 7.30, serum bicarbonate > 15 mEq/l, serum tonicity > 320 mOsm/l, serum
anion gap is variable, and stupor or coma are present [1].
The calculations of this section should be used as a supplement to the established guidelines for
patients with severe hyperglycemia [1-2, 4]. These calculations are based on measurements of
weight, serum tonicity, and net water and cation losses. Table 4 shows the proposed sequence of
calculations. Losses of water, sodium and potassium through osmotic diuresis occur in two
stages, during development of hyperglycemia and during treatment while  remains
elevated. Replacement solutions should reflect, in both volume and composition, the calculated
losses in these stages.
WATER AND ELECTROLYTE DEFICITS ON ADMISSION
1
Weight deficit:  
2 Body water in the normal state:  Obtained from available anthropometric formulas using sex, age, height,weight, and in some instances race
3
Total body sodium plus potassium in the normal state:  
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4
Body water on admission with hyperglycemia prior to any treatment:  
5 Total body sodium plus potassium at hyperglycemia: 
6
Total sodium plus potassium deficit on admission with hyperglycemia:  
7
Volume deficit (required volume of replacement solution):  
8
Electrolyte composition of replacement solution:  
ONGOING FLUID AND ELECTROLYTE LOSSES DURING TREATMENT
1 Urine flow rate. Monitoring from treatment onset: 
2
Measurements in the first urine sample, prior to the starting any infusion, and repeatedly as  decreases: 
3
Calculation of replacement solution  
TABLE 4: Calculations of fluid deficits during management of extreme hyperglycemia
Water deficit at presentation is calculated as the difference between body water in the normal
state and at presentation with hyperglycemia. Body water in the normal state is calculated by an
appropriate anthropometric formula utilizing body weight at the normal state. Body water deficit
is the difference between the normal body weight and the weight at presentation with
hyperglycemia. Body water at presentation is the difference between the normal body water and
the water deficit.
The water deficit determines the required volume of the initial replacement solution. Body
monovalent cations are also calculated in the normal state and at presentation. The difference in
monovalent cations between the baseline normal state and at presentation with hyperglycemia
determines the cation composition of the initial replacement solution. Monitoring of ongoing
losses of urine volume, sodium and potassium guide the selection of the additional replacement
solutions. To illustrate these calculations, we will use data from an actual patient with preserved
renal function who developed extreme hyperglycemia.
A 14-year-old boy with no prior history of diabetes mellitus was admitted with coma and
seizures in the preceding 12 hours (Patient 2). He had a 10-day history of polyuria and profound
thirst. He consumed up to 7.5 liters (2 gallons) per day of fluids, including solutions containing
2013 Tzamaloukas et al. Cureus 5(3): e110. DOI 10.7759/cureus.110 10 of 17
electrolytes. His blood pressure was unrecordable on admission. Six hours later, he was
transferred to the Intensive Care Unit (ICU) of a second hospital after intravenous administration
of insulin, pressors, and 5 liters of 0.154 m saline with potassium chloride, plus tracheal
intubation and mechanical ventilation because of rising arterial . His height was 160 cm.
Body weight was 46.6 kg at his pediatrician’s office 10 days prior to this admission, 36.8 kg on
admission to the first hospital, and 40.2 kg upon admission to the second hospital.
At the second hospital, initial blood pressure was 64/36 mm Hg and pulse rate 145 per minute.
Urinalysis revealed glucose > 55.6 mmol/l (> 1000 mg/dl) and large amounts of acetone.
Treatment continued with intravenous insulin and 0.3 L per hour of 0.154 m saline containing
potassium acetate and potassium phosphate (total potassium concentration 35 mEq/l).
Throughout the course of the first 48 hours in the ICU of the second hospital, he exhibited
marked diuresis, but urine volumes were not recorded.
Table 5 shows serum chemistries in the first 18 hours of treatment. The first set of values was
obtained on admission in the first hospital, when he exhibited extreme hypertonicity and life-
threatening hypovolemia, addressed by large saline infusions. Parallel to volume repletion,
correction of the extreme hypertonicity should be a primary aim of the treatment. To fulfill the
recommendations of the guidelines [1-2, 4] as discussed earlier,  should be normalized
between 28.3 and 42.5 hours and corrected  should decrease and be normalized between
32.2 and 48.3 hours.
Glucose mmol/l
(mg/dl)
Sodium
Measured mEq/l
Potassium  
mEq/l
Chloride  
mEq/l
Total CO2
mmol/L
Anion Gap
mEq/L
Tonicity  
mOsm/l
Sodium
Corrected mEq/l
123.7 (2226) 135 2.4 94 9 32 393.7 169.0
99.7 (1794) 148 3.3 112 9 27 391.7 175.1
98.9 (1618) 155 3.3 119 14 22 399.9 179.3
70.7 (1273) 159 2.1 128 13 18 388.7 177.8
68.8 (1239) 162 2.1 131 14 17 392.8 180.2  
TABLE 5: Sequential serum chemistry values in a hyperglycemic patient with profound diuresis treated with insulin infusion
plus large fluid infusions. Patient 2.
Additional measurements on admission: In serum, urea 25.4 mmol/l, creatinine 672.0 µmol/l. In arterial blood, pH 7.209, pO2 226
mm Hg (on 6 L/min oxygen by face mask), pCO2 16 mm Hg, and bicarbonate 6.2 mEq/L. Additional serum measurements
simultaneous with the last blood glucose value: Urea 19.3 mmol/l, creatinine 336.0 µmol/l.
Additional measurements on admission: In serum, urea 25.4 mmol/l, creatinine 672.0 μmol/l. In
arterial blood, pH 7.209,  226 mm Hg (on 6 L/min oxygen by face mask),  16 mm Hg,
and bicarbonate 6.2 mEq/L. Additional serum measurements simultaneous with the last blood
glucose value: Urea 19.3 mmol/l, creatinine 336.0 μmol/l.
During the period depicted in Table 5, serum tonicity did not change in patient 2 despite a
decrease in  by almost 55.6 mmol/l at an average hourly rate of 3.2 mmol/l, while
corrected  progressively increased in each sequential measurement. During the same
period, the measured  increased by 2.74 mEq/l for each 5.6 mmol/L decrease in .
This rate of increase in  is substantially higher than the one in Katz’s formula. Figure 5
shows a progressive decline of the fraction of hypertonicity caused by hyperglycemia and a
progressive rise of the fraction caused by external changes in water, sodium and potassium
balance in the successive serum chemistry measurements shown in Table 5.
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FIGURE 5:
Percents of hypertonicity attributable to hyperglycemia (blue) and to the net external losses of
water and monovalent cations (red) corresponding to the serum glucose measurements
presented in Table 5. Note that the absolute value of hypertonicity was almost the same in all five
measurements. Hypertonicity secondary to hyperglycemia was computed as 2.4 mmol/l per 5.6
mmol/l rise in serum glucose concentration(19, 20).
At the time of the last set of values shown in Table 5, body weight was not measured, serum
osmolality was 424 mOsm/kg, while in urine osmolality was 526 mOsm/kg, sodium 25 mEq/l and
potassium 28 mEq/l. He subsequently received intravenously large volumes of hypotonic saline
with additional potassium salts and had a gradual improvement in his laboratory values and a
slower improvement in his clinical status. He was extubated five days later and remained in the
hospital for a total of 25 days. He was discharged on maintenance insulin. His serum creatinine
returned to values below 80 μmol/L. His mental status cleared, but he exhibited severe
depression.
Using Table 4, the following estimates of water and cation deficits at presentation were
calculated for patient 2: According to the Mellits-Cheek formula [47], shown as formula 6 in
Table 2, body water in the normal state was 30.4 l; the sum of total body sodium, plus potassium,
in the normal state was 4256.0 (= 140 x 30.4) mEq; on admission to the first hospital, weight
deficit was 9.8 (= 46.6 – 38.8) kg and body water was 20.6 (= 30.4 – 9.8) l; total body sodium, plus
potassium, on the same admission was 3481.4 (= 169 x 20.6) mEq; sodium, plus potassium, deficit
on the same admission was 774.6 (= 4256.0 – 3481.4) mEq.
The ideal replacement solution for losses that took place during development of hyperglycemia
should have consisted of a volume of 9.8 l and a combined concentration of sodium, plus
potassium, of 79.0 (= 774.6/9.8) mEq/l, or an isotonic infusion of 5.53 (= 774.6/140) l, plus an
additional infusion of 4.27 (= 9.8 – 5.53) l of water. Instead, patient 2 continued to receive
hypertonic infusions of salt with potassium salts, while he continued having hypotonic osmotic
diuresis. Consequently, serum tonicity did not change, despite the large drop in , while
corrected  rose continuously (Table 5) showing progressively larger water deficits.
Further calculations verified the progressive increase in water deficit during treatment suggested
by Figure 5. During the stay in the first hospital, body weight increased from 36.8 to 40.2 kg
indicating that 3.4 l of the infused 5 l were retained. On admission to the second hospital at a
weight of 40.2 kg, the calculated deficit of sodium, plus potassium, had decreased from 774.6 to
only 56 mEq, while the water deficit had increased from 4.27 to 6.4 l. Changes in body weight
were not recorded subsequently. However, the rising values of corrected  (Table 5)
indicate further increases in the deficit of body water relatively to body sodium, plus potassium.
Management of hyperglycemic abnormalities in body potassium
and acid-base balance
In addition to volume and tonicity, potassium balance and acid-base balance may become
critical issues during treatment of hyperglycemia. Other issues, such as management of
phosphate balance, are addressed in the guidelines [1-2, 4]. Hyperglycemia disrupts both the
internal and the external potassium balance. Transfers of potassium outside the cells are caused
by insulin deficits and hypertonicity [48]. Whether ketoacidosis or lactic acidosis also affect these
transfers has been disputed because the transfer of monocarboxylic acids (e.g. ketoacids, lactic
acid) through transporters in cell membranes has no direct effects on potassium transport [48].
However, changes in intracellular pH that accompany organic acidosis have indirect effects on
potassium transport through other membrane transporters and exchangers [49]. In addition to 
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, multivariate analysis identified arterial pH and serum anion gap as predictors of
plasma potassium concentration in a clinical study of diabetic ketoacidosis [50]. The disturbance
of internal potassium balance secondary to hyperglycemia is clearly demonstrated by the
frequency and severity of hyperkalemia in severe dialysis-associated hyperglycemia [51].
In patients with preserved renal function, loss of potassium through osmotic diuresis tempers
the hyperkalemic effect of hyperglycemia. Serum potassium concentration at presentation may
be high, normal, or low. Severe hypokalemia may have life-threatening consequences [52]. To
address the eventuality of profound hypokalemia, immediate measurement of plasma potassium
concentration by a blood gas analyzer has been proposed [53].
Low, or even normal, presenting serum potassium concentration  in hyperglycemia is
associated with large potassium deficits.
During treatment of hyperglycemia, potassium is lost from the extracellular compartment to
both the intracellular compartment and the urine, as long as there is osmotic diuresis.
Furthermore, infusion of large amounts of fluids not containing potassium salts may lead to
further decreases in . Infusion of insulin and correction of hypertonicity cause potassium
entry into the intracellular compartment. The effects of insulin on the intracellular transfers of
potassium and glucose differ (54). A large decline in  without any substantial change in 
 was documented after administration of insulin to an anuric patient with severe
hyperglycemia (55). Administration of potassium salts with saline infusions should precede
insulin infusion if  is not elevated at presentation with hyperglycemia [1-2, 4].
Despite administration of large amounts of potassium salts, intracellular transfers and urinary
losses of potassium may result in persistent or worsening hypokalemia during treatment (Table
5). The consequences are potentially ominous [56]. Adjustments in the amounts of potassium
infused guided by  are frequently needed in severe hyperglycemia. Correction of large
potassium deficits may require more than one week [57].
Multiple acid-base abnormalities may be present in hyperglycemia [58-59]. We will discuss only
respiratory acidosis and metabolic acidosis because of their potential severity. Respiratory
acidosis requiring intubation, as in the second patient of this report, may result from
hypokalemia [52, 56-57], associated respiratory or neurological injury, or, in patients on chronic
dialysis, hypervolemia [58]. Lactic acidosis is frequently encountered in severe hyperglycemic
syndromes and may be confused with ketoacidosis [60]. Measurement of serum lactate level
should accompany determination of serum ketone bodies at presentation with hyperglycemia
and high-anion gap metabolic acidosis.
Appropriate response to treatment of DKA or lactic acidosis with insulin, plus fluids, is a rising
serum  and decreasing serum anion gap, as in Table 5. Repeated measurements of ketone
bodies and serum lactate are needed only if serum TCO2 decreases or anion gap increases during
treatment. Sodium bicarbonate administration may be used in severe cases (2).
Limitations
There are several potential sources of error during treatment of severe hyperglycemia with
profound water and electrolyte deficits. Water deficit estimates are based on body weight
measurements, which are often inaccurate or unknown if recent weight determinations prior to
the hyperglycemic episode are not available. The accuracy of the weighing procedure, often poor
in hospital wards, should receive special emphasis during treatment of extreme hyperglycemia.
Bedridden patients create added complexities in weight measurement.
The methods of estimating body water may further complicate the calculation of water deficits.
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Even at normal body weight, the margin of error of the anthropometric formulas estimating body
water is in the order of a few liters. Used in subjects with substantial water deficits, these
formulas systematically overestimate body water [61-64]. This was our reason for basing the
estimates of body water on the normal euglycemic state in this report.
The uncertainties about the accuracy of the corrected  in hyperglycemic patients with
preserved renal function have been discussed. Other influences that may cause deviations of the
ratio  from Katz’s prediction include extracellular volume abnormalities [65-66],
internal transfers of potassium [67], and the degree of hyperglycemia [68]. Among these,
extracellular volume abnormalities are, by far, the most important [69]. Also, the rates of transfer
of the infused potassium into the intracellular compartment can be inferred from external
balances, but cannot be directly measured in the clinical practice and, more importantly, cannot
be predicted. The final source of potential errors is loss of fluid or cations from the
gastrointestinal tract, the respiratory system or the skin during treatment.
For all these reasons, frequent monitoring of the clinical status, especially volume and
neurological status, and urine output of the patients, as well as of the relevant laboratory values,
is critical during treatment. In addition to indicating whether clinical status and laboratory tests
are improving, monitoring allows comparisons with the predictions of the quantitative system
shown in Table 4. Deviations of the measurements from the predicted values should cause a
search for conditions which may cause such deviations, for example, large extrarenal losses.
Conclusions
Repletion of deficits in volume and correction of the hypertonicity encountered in
severe hyperglycemia should be made by using quantitative estimates of these deficits.
Comparison of these estimates to the corresponding changes in volume and tonicity during
treatment allows detection of deviations from desired end-points. Detection of such deviations
warrants reexamining the calculation of the quantitative estimates and for a search for other
conditions, such as ongoing extrarenal losses, affecting fluid solute and solute balances. Deficits
of potassium, for which currently there are no quantitative estimates, and correction of acid-
base abnormalities are also critical parts of the management of severe hyperglycemia. Regardless
of whether quantitative estimates predicting deficits are available or not, monitoring of the
clinical status and of appropriate laboratory values intervals are the critical parts of the
management of extreme hyperglycemia.
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